DNA-Protein-Interaction (DPI)-ELISA Assay for PPAR-γ Receptor Binding

Area of Science:

• Molecular Biology
• Biochemistry
• Drug Discovery

Background:

• Peroxisome proliferator-activated receptor (PPAR)-γ dysregulation is implicated in diabetes, obesity, inflammation, and cancer.
• Current methods for assessing PPAR-γ activity are often costly, time-consuming, and lack quantitative accuracy.
• There is a need for a rapid and reliable assay to study PPAR-γ activity and identify therapeutic ligands.

Purpose of the Study:

• To develop a sensitive and reproducible assay for measuring PPAR-γ activity.
• To facilitate the identification of novel PPAR-γ ligands for therapeutic development.

Main Methods:

• A novel colorimetric assay, DNA-Protein-Interaction enzyme-linked immunosorbent assay (DPI-ELISA), was developed.
• This assay utilizes a double-stranded oligonucleotide probe with the PPRE consensus sequence to capture activated PPAR-γ, differing from traditional antibody-based ELISA.
• The method is based on ELISA principles but specifically detects activated PPAR-γ.

Main Results:

• The DPI-ELISA assay demonstrated sensitivity in detecting PPAR-γ activity.
• The assay allows for the specific detection of activated PPAR-γ by using a DNA probe instead of an antibody for capture.
• This method provides a quantitative measure of PPAR-γ activity.

Conclusions:

• The DPI-ELISA is a valuable tool for studying PPAR-γ.
• This assay can accelerate the discovery of novel PPAR-γ ligands.
• The DPI-ELISA supports the development of therapeutic strategies for diseases associated with PPAR-γ signaling dysregulation.